Literature DB >> 17222319

Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.

Jasmohan S Bajaj1, Kia Saeian, Matthew D Verber, Darrell Hischke, Raymond G Hoffmann, Jose Franco, Rajiv R Varma, Stephen M Rao.   

Abstract

OBJECTIVES: To compare inhibitory control test (ICT), a simple/rapid test of attention, to a standard psychometric battery (SPT) to diagnose minimal hepatic encephalopathy (MHE) and predict development of overt hepatic encephalopathy (OHE) in cirrhotic patients.
METHODS: Fifty nonalcoholic cirrhotics and 50 age/educational-status-matched controls were given ICT and SPT in the same sitting. Performance impaired beyond two standard deviations of controls was considered MHE in cirrhotics. ICT results (lure/target response and lures/person) were compared between controls and cirrhotics and within cirrhotics with/without MHE. Receiver-operating characteristic analysis was used to study ICT for MHE diagnosis. Twenty subjects were administered SPT and ICT twice to assess test-retest reliability. All cirrhotics were followed routinely for the development of OHE.
RESULTS: Cirrhotics performed worse than controls on SPT and ICT. Using SPT, 39 cirrhotics had MHE. ICT was administered faster than SPT (15 vs 37 min). Cirrhotics with MHE had significantly higher lure (28%vs 3%) and lower target response (91%vs 96%) compared with those without MHE. Lure/person >5 had 90% sensitivity/specificity for MHE diagnosis. AUC for receiver-operating characteristic for lures alone was 95.8%. Lure and target responses were highly correlated (r= 0.9) between sessions showing high test-retest reliability. Five (10%) patients developed OHE on f/u of 26 +/- 10 months; all five had been diagnosed with MHE using ICT and SPT. None of the five patients with discordant results on SPT and ICT developed OHE.
CONCLUSIONS: ICT has good sensitivity/specificity for MHE diagnosis, is reliable and is equivalent to SPT for predicting OHE development.

Entities:  

Mesh:

Year:  2007        PMID: 17222319     DOI: 10.1111/j.1572-0241.2007.01048.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  51 in total

Review 1.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Hepatobiliary quiz-5 (2013).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-03

Review 3.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 4.  Brain edema: a valid endpoint for measuring hepatic encephalopathy?

Authors:  Chantal Bémeur; Cristina Cudalbu; Gitte Dam; Alexander S Thrane; Arthur J L Cooper; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-06-07       Impact factor: 3.584

Review 5.  Diagnosis of minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  J Clin Exp Hepatol       Date:  2014-07-31

Review 6.  Current and future diagnosis of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2010-03-06       Impact factor: 3.584

7.  Diagnosis of Minimal HE-And the Temptation of Easy Solutions.

Authors:  Karin Weissenborn
Journal:  J Clin Exp Hepatol       Date:  2012-12

8.  Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.

Authors:  Jasmohan S Bajaj; Masoumeh Sikaroodi; Andrew Fagan; Douglas Heuman; HoChong Gilles; Edith A Gavis; Michael Fuchs; Javier Gonzalez-Maeso; Shahzor Nizam; Patrick M Gillevet; James B Wade
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-08-28       Impact factor: 4.052

9.  Use of ImPACT to diagnose minimal hepatic encephalopathy: an accurate, practical, user-friendly internet-based neuropsychological test battery.

Authors:  Matthew Tsushima; William Tsushima; Vincent Tsushima; Nelson Lim; Erika Madrigal; Christian Jackson; Michel Henry Mendler
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

10.  Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease.

Authors:  Jennifer C Lai; Michael L Volk; Debra Strasburg; Neil Alexander
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.